Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00583596 · ClinicalTrials.gov registry record · NA
Closure Of Patent Ductus Arteriosus With the AMPLATZER Duct Occluder the AMPLATZER® Duct Occluder
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 436
- Enrollment target
NCT00583596 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 436 participants.
The verdict
NCT00583596, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 436 participants
- Enrollment target
Study Summary
AGA-004 - The objective of the study is to determine safety, effectiveness and clinical utility of the AMPLATZER Duct Occluder in patients with patent ductus arteriosus. AGA-007 - The objective of this study is to evaluate the long term safety and effectiveness issues that may not have have been adequately addressed during AGA-004.
Interventions
- DEVICE Device closure with AMPLATZER Duct Occluder
- OTHER Objective Performance Criteria
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 436 participants |
| Start Date | 1999-10 |
| Est. Completion | 2009-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00583596
The ClinicalTrials.gov registry entry for NCT00583596 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 436 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Device closure with AMPLATZER Duct Occluder is the first listed.
NCT00583596 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00583596 about?
NCT00583596 is a clinical study titled "Closure Of Patent Ductus Arteriosus With the AMPLATZER Duct Occluder the AMPLATZER® Duct Occluder". AGA-004 - The objective of the study is to determine safety, effectiveness and clinical utility of the AMPLATZER Duct Occluder in patients with patent ductus arteriosus. AGA-007 - The objective of this study is to evaluate the long term safety and effectiveness issues that may not have have been ade...
What is the current status of trial NCT00583596?
This trial is currently completed. It is a NA study. The enrollment target is 436 participants. The study started on 1999-10. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00583596?
The interventions under investigation include: Device closure with AMPLATZER Duct Occluder (DEVICE), Objective Performance Criteria (OTHER).
Who is sponsoring clinical trial NCT00583596?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.